PDA Aseptic Manufacturing and Regulatory Science Symposium 2027 【Osaka】
PDA Aseptic Manufacturing and Regulatory Science Symposium 2027 will take place on October 21–22, 2027, in Osaka, Japan. This international symposium focuses on aseptic pharmaceutical manufacturing and regulatory science. It is relevant to professionals involved in aseptic processing technologies, PIC/S GMP Annex 1, contamination control strategies (CCS), aseptic process simulation (APS), environmental monitoring, quality control and quality assurance. The official 2027 symposium website provides registration information, standard registration fees, and contact details for corporate exhibitions and sponsorship opportunities.
Symposium Overview and Objectives
The Parenteral Drug Association (PDA) is an international scientific organization serving professionals involved in the development, manufacturing, quality control and regulation of pharmaceutical and healthcare products. It promotes scientific and technological advancement and knowledge sharing in pharmaceutical technologies, Good Manufacturing Practice (GMP), validation and related disciplines.
The Symposium of Aseptic has been organized to support the effective implementation of PIC/S GMP Annex 1. Contamination control in sterile pharmaceutical manufacturing, equipment and process qualification, quality risk management, and the interpretation and implementation of regulatory requirements are important considerations for pharmaceutical manufacturers.
PDA Aseptic Manufacturing and Regulatory Science Symposium 2027 is a two-day international symposium in Osaka dedicated to topics associated with aseptic pharmaceutical manufacturing and regulatory science.
Official information: Parenteral Drug Association / PDA Japan Chapter (Japanese)
PDA Aseptic Manufacturing and Regulatory Science Symposium 2027: Event Information
- Official name: PDA Aseptic Manufacturing and Regulatory Science Symposium 2027
- Japanese name: PDA無菌シンポジウム2027 (Japanese rendering)
- Dates: October 21 (Thu)–October 22 (Fri), 2027
- Event hours: Detailed schedule under preparation. The PDA registration system lists the overall event period as October 21 at 9:00 to October 22 at 17:00.
- Location: Osaka, Japan
- Venue and address: Under preparation
- Organizer: PDA (Parenteral Drug Association)
- Conference Chair and Organizing Committee: Under preparation
- Symposium theme: Under preparation
- Format: In-person registration is available. Online streaming arrangements and other details are under preparation.
The 2026 symposium took place at Congress Square Osaka Nakanoshima. However, the specific venue for the 2027 symposium has not yet been announced. Please refer to forthcoming official information for the symposium theme, speakers and co-organizing organizations.
Official information: PDA Aseptic Manufacturing and Regulatory Science Symposium 2027
Organizer, Administration and Contact Information
- Organizing organization: PDA (Parenteral Drug Association)
- Program and registration inquiries: PDA Asia Pacific
- E-mail: asia-pacific@pda.org
- Registration contact telephone: +65 6496 5504
- Exhibition and sponsorship inquiries: Cizlie Sunto
- E-mail: sunto@pda.org
- Training course inquiries: training@pda.org
The 2026 symposium was co-hosted by PDA Headquarters, PDA Asia Pacific and PDA Japan Chapter. Please refer to forthcoming official announcements for the co-organizing arrangements, Conference Chair and Organizing Committee of the 2027 symposium.
Official information: 2027 Symposium Contact Information
Related Technologies and Key Research Areas
Sterile pharmaceutical manufacturing requires comprehensive control of manufacturing equipment, raw materials, environments, processes and personnel to prevent contamination of products with microorganisms, particles, endotoxins and other contaminants. Technical and research areas associated with the PDA Symposium of Aseptic include:
- PIC/S GMP Annex 1: Regulatory requirements for sterile pharmaceutical manufacturing, quality risk management and practical GMP implementation.
- Contamination Control Strategy (CCS): An integrated approach to assessing and controlling contamination risks associated with facilities, processes, personnel and raw materials.
- Aseptic Process Simulation (APS): Evaluation of aseptic processing operations through media fills and related simulation methods.
- Environmental Monitoring (EM): Monitoring and assessment of microorganisms, airborne particles and surface contamination in cleanroom environments.
- Barrier technologies and aseptic filling: Isolators, Restricted Access Barrier Systems (RABS) and aseptic filling equipment.
- Sterilization, filtration and single-use technologies: Quality management and manufacturing applications of sterilizing-grade filters, integrity testing, single-use bags, tubing and fluid transfer systems.
- QC, QA and rapid microbiological methods: Sterility testing, bioburden testing, endotoxin testing, rapid microbiological methods (RMM), quality assurance and validation.
- Biopharmaceuticals and cell and gene therapy products: Manufacturing technologies and quality management related to therapeutic antibodies, injectable products, and cell and gene therapies.
These are examples of technical areas associated with sterile pharmaceutical manufacturing and previous PDA aseptic manufacturing symposia. They are not confirmed lecture topics or session categories for the 2027 symposium.
Related information: PDA Aseptic Manufacturing and Regulatory Science Symposium 2026
Related Regulatory Information: PIC/S GMP Annex 1
The 2022 revision of PIC/S GMP Annex 1 on the manufacture of sterile medicinal products entered into force on August 25, 2023, except for point 8.123 concerning lyophilization, which became applicable on August 25, 2024.
On October 28, 2026, PIC/S announced the entry into force of PI 058-1, an interpretation document addressing major changes in Annex 1. Developed through collaboration involving PIC/S, EMA and WHO, the document supports interpretation of key changes in the revised Annex 1 and greater consistency in inspection practices.
These regulatory developments provide important background for pharmaceutical companies considering aseptic process design, contamination control strategies and quality assurance systems. However, coverage of PI 058-1 in the 2027 symposium program has not yet been confirmed.
Official information: PIC/S Official News and Annex 1 Updates
Program, Speakers and Call for Abstracts
The official 2027 symposium website provides information on event dates, location, registration, exhibitions and sponsorship. Please refer to forthcoming official announcements for the detailed program.
- Symposium theme: Under preparation
- Detailed program and schedule: Under preparation
- Keynote presentations, special lectures and speakers: Under preparation
- Presentations by regulatory authorities: Under preparation
- Poster presentations and abstract submission: Under preparation
- Presentation languages and simultaneous interpretation: Under preparation
- Related workshops and training: Under preparation
The 2026 symposium focused on the practical implementation of GMP and Annex 1, including regulatory developments, CCS, aseptic pharmaceutical manufacturing, QC and QA. The theme, speakers and session structure of the 2027 symposium may differ from those of the previous event.
Official information: 2027 Symposium Program Information
Registration, Fees and Potential Attendees
Registration status: Official registration page available as of November 16, 2026.
The PDA official website offers individual and group registration options. The following standard registration fees are listed on the official 2027 symposium website.
| Registration Category | Standard Fee (USD) |
|---|---|
| PDA Member | USD 499 |
| Government Member Only | USD 199 |
| Health Authority Member Only | USD 199 |
| Academic Member Only | USD 199 |
| Non-Member | USD 699 |
The official registration system (Glue Up) lists two-day conference passes, registration categories in Japanese yen (JPY) and US dollars (USD), and early-bird registration categories. Some categories require eligibility verification and approval. Please check the official registration page for JPY prices, early-bird fees and deadlines, registration deadlines, taxes and other applicable conditions.
- Potential attendees: Manufacturing, manufacturing technology, quality control (QC), quality assurance (QA), regulatory affairs and R&D professionals from pharmaceutical and biopharmaceutical companies.
- Related fields: Sterile pharmaceutical manufacturing, regenerative medicine products, manufacturing equipment, microbiological testing, validation, regulatory science, research instrument and reagent companies.
- Registration inquiries: asia-pacific@pda.org
Official registration: Register for PDA Aseptic Manufacturing and Regulatory Science Symposium 2027
Corporate Exhibitions, Sponsorship and Related Products
Exhibition and sponsorship status: Inquiry forms are available on the official website.
PDA Aseptic Manufacturing and Regulatory Science Symposium 2027 provides inquiry forms for prospective sponsors and exhibitors. Companies interested in participating can request further information through the Become a Sponsor and/or Exhibitor section of the official symposium website.
Products and technologies associated with sterile pharmaceutical and biopharmaceutical manufacturing include:
- Manufacturing equipment: Aseptic filling systems, isolators, RABS, cleanroom equipment, sterilization and decontamination systems.
- Single-use products: Single-use bags, tubing, aseptic connectors and disconnectors, and fluid transfer systems.
- Filtration and sterilization technologies: Sterilizing-grade filters, filter integrity testing instruments and sterilization validation products.
- Quality control and analytical instruments: Particle counters, microbiological testing instruments, endotoxin testing and environmental monitoring systems.
- Manufacturing process control: pH and conductivity measurement, Process Analytical Technology (PAT), manufacturing data management, laboratory and manufacturing automation, and quality systems.
These are examples of relevant industries and technologies, not a confirmed list of products or companies exhibiting at the 2027 symposium.
- Corporate exhibitions and sponsorship: Inquiry forms available
- Exhibition and sponsorship packages and fees: Under preparation
- Application deadlines and booth specifications: Under preparation
- Exhibitor and sponsor lists: Under preparation
- Contact: Cizlie Sunto
- E-mail: sunto@pda.org
Official information: Sponsor & Exhibitors | Request Exhibition and Sponsorship Information
Venue and Access
Location: Osaka, Japan
- Venue name: Under preparation
- Venue address: Under preparation
- Nearest stations and transportation access: Under preparation
- Designated hotel and accommodation information: Under preparation
The 2026 symposium took place at Congress Square Osaka Nakanoshima within Nakanoshima Qross. However, the specific venue for the 2027 symposium has not yet been confirmed. Please consult the official 2027 venue announcement before arranging transportation and accommodation.
PDA recommends booking accommodation directly with its officially designated hotel when applicable. Please exercise caution regarding unsolicited communications from unofficial accommodation agents claiming to represent PDA.
Official information: 2027 Symposium Location and Travel
Official Websites
PDA Aseptic Manufacturing and Regulatory Science Symposium 2027
Official Registration for the 2027 Symposium
Reference: 2026 Symposium Official Website
PIC/S Official Regulatory Updates
Information checked November 16, 2026. Event dates, location, standard registration fees, registration options, and exhibition and sponsorship contact information are based on PDA’s official 2027 symposium information. The specific venue, theme, speakers, program, registration conditions and exhibition requirements are subject to change. Please refer to the official 2027 symposium website for the latest information.


